Quantifying the effects of promoting smokeless tobacco as a harm reduction strategy in the USA

Tobacco Control

Volumn 19, Issue 4, 2010, Pages 297-305

  Mejia, Adrienne B ^a   Ling, Pamela M ^a   Glantz, Stanton A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HARM REDUCTION; HUMAN; METHODOLOGY; MONTE CARLO METHOD; RISK ASSESSMENT; SMOKELESS TOBACCO; SMOKING CESSATION; STATISTICS; UNITED STATES;

HARM REDUCTION; HUMANS; MONTE CARLO METHOD; RISK ASSESSMENT; SMOKING CESSATION; TOBACCO, SMOKELESS; UNITED STATES;

EID: 77955283161     PISSN: 09644563     EISSN: 14683318     Source Type: Journal    
DOI: 10.1136/tc.2009.031427     Document Type: Article

References (47)

1. Gartner CE, Hall WD. Should Australia lift its ban on low nitrosamine smokeless tobacco products? Med J Aust 2008;188:44-6.
2. Britton J. Should doctors advocate snus and other nicotine replacements? Yes. Br Med J 2008;336:358.
3. Macara AW. Should doctors advocate snus and other nicotine replacements? No. Br Med J 2008;336:359.
4. Royal College of Physicians. Harm reduction in nicotine addiction: helping people who can't quit. A report by the tobacco advisory group of the royal college of physicians. London: Royal College of Physicians of London, 2007. http://www. rcplondon.ac.uk/pubs/contents/4fc74817-64c5-4105-951e-38239b09c5db.pdf (accessed 20 Apr 2008).
5. Roth HD, Roth AB, Liu X. Health risks of smoking compared to Swedish snus. Inhal Toxicol 2005;17:741-8.
6. Severson HH, Forrester KK, Biglan A. Use of smokeless tobacco is a risk factor for cigarette smoking. Nicotine Tob Res 2007;9:1331-7.
7. Tomar SL, Alpert HR, Connolly GN. Patterns of dual use of cigarettes and smokeless tobacco among U.S. males: findings from national surveys. Tob Control 2010;19:104-9.
8. Tomar SL. Is use of smokeless tobacco a risk factor for cigarette smoking? The U.S. experience. Nicotine Tob Res 2003;5:561.
9. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Health effects of smokeless tobacco products. Brussels: Health and Consumer Protection Directorate-General, European Commission, 2008.
10. Levy DT, Mumford EA, Cummings KM, et al. The relative risks of a low-nitrosamine smokeless tobacco product compared with smoking cigarettes: estimates of a panel of experts. Cancer Epidemiol Biomarkers Prev 2004;13:2035-42.
11. Institute of Medicine, Stratton K, Shetty P, Wallace R, Bondurant S, eds. Clearing the smoke: assessing the science base for tobacco harm reduction. Washington, DC: National Academies Press, 2001.
12. Bombard JM, Rock VJ, Pederson LL, et al. Monitoring polytobacco use among adolescents: do cigarette smokers use other forms of tobacco? Nicotine Tob Res 2008;10:1581-9.
13. Mejia A, Ling P. Tobacco industry consumer research on smokeless tobacco users and product development. Am J Public Health 2010;100:78-87.
14. Dorfman B. Altria to buy Ust for $10.4 Billion. Reuters, Chicago 2008. http://www. reuters.com/article/rbssFinancialServicesAndRealEstateNews/ idUSBNG23930220080908 (accessed 10 Sep 2008).
15. Wilson D, Creswell J. Where there's no smoke, altria hopes there's fire. New York, NY: New York Times. http://www.nytimes.com/2010/01/31/business/31altria.html (accessed 5 Feb 2010).
16. British American Tobacco. Selling snus, 2008. http://www.bat.com/group/sites/ uk__3mnfen.nsf/vwPagesWebLive/80A9A7A1ECA96949C1257314004EF6A7? opendocument&SKN1/41&TMP1/41 (accessed April 19, 2008).
17. Forbes.com. Rpt Bat Unveils Acquisition of Skandinavisk Alongside in-Line Fy Results Update. http://www.forbes.com/feeds/afx/2008/02/28/afx4708205.html (accessed 21 Apr 2008).
18. Dillard JE. Senior Vice President Regulatory Affairs, Altria Client Services. Letter to US Food and Drug Administration Re: Dockett No. FDA-2009-N-0294 (74 Federal Register 31457 (July 1, 2009)) Request for Comments: Regulation of Tobacco Products under the Family Smoking Prevention and Tobacco Control Act 2009.
19. McGrath WA, of behalf of RAI Services Company (a wholly-owned service company of Reynolds American Inc.). Letter to US food and drug administration re: regulation of tobacco products; request for comments, Dockett No. FDA-2009-N-0294 2009.
20. Wetter DW, McClure JB, de Moor C, et al. Concomitant use of cigarettes and smokeless tobacco: prevalence, correlates, and predictors of tobacco cessation. Prev Med 2002;34:638-48.
21. Gilpin E, Pierce JP, Goodman J, et al. Reasons smokers give for stopping smoking: do they relate to success in stopping? Tob Control 1992;1:256-63.
22. Centers for Disease Control and Prevention. Cigarette smoking among adultseUnited States, 2006. MMWR 2007;56:1157-61.
23. Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the interheart study: a case-control study. Lancet 2006;368:647-58.
24. Boffetta P, Straif K. Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 2009;339:b3060.
25. Alguacil J, Silverman DT. Smokeless and other noncigarette tobacco use and pancreatic cancer: a case-control study based on direct interviews. Cancer Epidemiol Biomarkers Prev 2004;13:55-8.
26. Boffetta P, Aagnes B, Weiderpass E, et al. Smokeless tobacco use and risk of cancer of the pancreas and other organs. Int J Cancer 2005;114:992-5.
27. Zheng W, McLaughlin JK, Gridley G, et al. A cohort study of smoking, alcohol consumption, and dietary factors for pancreatic cancer (United States). Cancer Causes Control 1993;4:477-82.
28. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007;369:2015-20.
29. Tomar S. Trends and patterns of tobacco use in the United States. Am J Med Sci 2003;326:248-54.
30. Nelson DE, Mowery P, Tomar S, et al. Trends in smokeless tobacco use among adults and adolescents in the United States. Am J Pub Health 2006;96:897-905.
31. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. National survey on drug use and health: prevalence estimates, standard errors, P values, and sample sizes 2005.
32. Fichtenberg C, Glantz S. Effect of smoke-free workplace on smoking behaviour: systematic review. Br Med J 2002;325:188.
33. UST. Ust Inc. Investors Day Conference (Webcast) 2007.
34. Foulds J, Furberg H. Is low-nicotine marlboro snus really snus? Harm Reduct J 2008;5:9.
35. International Agency for Research on Cancer. Smokeless tobacco and some tobacco-specific n-nitrosamines. Lyon, France: IARC Press, 2007.
36. Gartner CE, Hall WD, Vos T, et al. Assessment of Swedish snus for tobacco harm reduction: an epidemiological modeling study. Lancet 2007;369:2010-14.
37. Tomar SL. Snuff use and smoking in U.S. men: implications for harm reduction. Am J Prev Med 2002;23:143-9.
38. Zhu S-H, Wang JB, Hartman A, et al. Quitting cigarettes completely or switching to smokeless: Do U.S. data replicate the swedish results? Tob Control 2009;18:82-7.
39. Savitz DA, Meyer RE, Tanzer JM, et al. Public health implications of smokeless tobacco use as a harm reduction strategy. Am J Public Health 2006;96:1934-9.
40. Ramstrom LM, Foulds J. Role of snus in initiation and cessation of tobacco smoking in Sweden. Tob Control 2006;15:210-14.
41. Reynolds American Inc. RAI CEO another year of strong earnings growth. 2008. http://www.reynoldsamerican.com/common/ViewPDF.aspx?postID1/41264 (accessed 13 Feb 2008).
42. Convenience Store News. R.J. reynolds expands snus tests, 2008. http://www. csnews.com/csn/search/article_display.jsp?vnu_content_id1/41003722971 (accessed 12 March 2008).
43. Thrasher JF, Niederdeppe J, Farrelly MC, et al. The impact of anti-tobacco industry prevention messages in tobacco producing regions: evidence from the US truth campaign. Tob Control 2004;13:283-8.
44. Ling PM, Neilands TB, Glantz SA. The effect of support for action against the tobacco industry on smoking among young adults. Am J Public Health 2007;97:1449-56.
45. Ling P, Neilands T, Glantz S. Factors associated with young adult smoking behaviour: a national survey. Am J Prev Med 2009;36:389-94.
46. Stead L, Perera R, Lancaster T. A systematic review of interventions for smokers who contact quitlines. Tob Control 2007;26:i83-8.
47. Lemmens V, Oenema A, Knut I, et al. Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Eur J Cancer Prev 2008;17:535-44.